Latin American Cooperative Oncology Group
Clinical trials sponsored by Latin American Cooperative Oncology Group, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study maps cancer treatment journeys across latin america Results expected Sep 2026 (estimated)
- AI may help tailor cancer care for seniors, study puts it to the test Results expected Jan 2027 (estimated)
- Can a nationwide charting of brain tumors reveal who is most affected? Results expected Mar 2027 (estimated)
- Chemo-Free hope for HER2+ breast cancer patients in new trial Results expected Apr 2027 (estimated)
- Can tumor markers guide future ovarian cancer treatments? Results expected Apr 2027 (estimated)
-
Can the sequence of chemo drugs tip the scales in HER2-negative breast cancer?
Disease control OngoingThis Phase 3 trial tests whether giving one type of chemotherapy before another, before surgery, changes the chances of staying cancer-free in people with locally advanced HER2-negative breast cancer. Participants receive either a taxane (docetaxel or paclitaxel) first, followed …
Phase 3 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Chemo-Free hope for HER2+ breast cancer patients in new trial
Disease control OngoingThis study tests whether certain women with early-stage HER2-positive breast cancer can be treated with a targeted drug combination (PHESGO™) without chemotherapy. Researchers use specific markers to select patients whose tumors are highly dependent on the HER2 pathway. The goal …
Phase 2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Why does cervical cancer persist despite prevention tools? a study seeks answers
Knowledge-focused OngoingResearchers are collecting detailed information from 524 women with cervical cancer across Latin America to understand why the disease remains common despite effective prevention tools. The study will document tumor types and cancer stages at diagnosis. The goal is to build a sol…
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Prostate cancer study pulled before it began
Knowledge-focused CancelledThis study was designed to see if a person's race or ethnicity changes how well a combination of drugs (niraparib, abiraterone acetate, and prednisone) works for a specific type of advanced prostate cancer. It planned to compare Black or Hispanic participants with White or Native…
Phase 2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC